Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
INCYTE CORP.
Incyte Corp.
XNAS: INCY
Turnaround Potential
Download real time
98.56
0.79
(
0.81
%)
66.63% Gain from 52W Low
877.8K
XNAS Volume
XNAS
08 May, 2026 5:30 PM (EDT)
Watchlist
Portfolio
Alert
My Notes
Board Meeting
The next board meeting for Incyte is on 19 May 2026 for the purpose of RBC 2026 Global Healthcare Conference
See details
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Technicals
Price History/Seasonality
Ownership
Politician Trades
Insider Deals
Corporate Actions
All
Dividend
Split
Board Meetings
About
Incyte - INCY - stock price prediction, stock price target, analyst ratings from 26 analysts
Incyte has a share price target of US$ 108, revenue growth forecast of 9.3%, and profit growth estimate of 8.3% for FY26, based on top 26 analyst calls.
Forecaster Screeners